Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
Clinical trial NCT03291158 · WITHDRAWN
Trial details
- NCT number
- NCT03291158
- Sponsor
- Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2018-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.